Latest Symmetry Tech Com (SMMR) Headlines Symme
Post# of 9
Posted On: 03/11/2014 9:52:59 AM
Latest Symmetry Tech Com (SMMR) Headlines
Symmetry Technologies Inc. moves to lab test and develop its "Inducible Expression System for Biosynthetic Production of Testerone in Men"
GlobeNewswire - Mon Oct 07, 7:00AM CDT
Symmetry Technologies Inc. (SMMR). is pleased to announce that it has initiated contact with a US based BioScience research and testing facility in its efforts to further develop the Company's "Inducible Expression System for Biosynthetic Production of Testosterone in Men"
Symmetry Technologies Inc. acquires the rights to a ground breaking technology that produces Biosynthetic Testosterone in men from A Houston PhD led Biomedical research firm. Technology estimated value up to 10 Billion Dollars.
GlobeNewswire - Wed Aug 14, 3:00PM CDT
Symmetry Technologies Inc. (OTC:SMMR) is pleased to announce the acquisition from a Houston, PhD led Biomedical research firm, all work product, rights, and interest in the "Inducible Expression System for Biosynthetic Production of Testosterone in Men" being developed by them.
Symmetry Technologies Inc. licenses a Human Rejuvenation Nutraceutical product from an FDA compliant laboratory. It will sell under the name "Resurgencell" in the yearly $200 billion USD Nutraceutical market
GlobeNewswire - Thu Aug 01, 3:04PM CDT
Symmetry Technologies Inc. (OTC:SMMR) is pleased to announce that it has licensed a Human Rejuvenation Nutraceutical product for retail sale from a US based FDA compliant laboratory that it will sell under the brand name "Resurgencell".
Symmetry Technologies Inc. moves to lab test and develop its "Inducible Expression System for Biosynthetic Production of Testerone in Men"
GlobeNewswire - Mon Oct 07, 7:00AM CDT
Symmetry Technologies Inc. (SMMR). is pleased to announce that it has initiated contact with a US based BioScience research and testing facility in its efforts to further develop the Company's "Inducible Expression System for Biosynthetic Production of Testosterone in Men"
Symmetry Technologies Inc. acquires the rights to a ground breaking technology that produces Biosynthetic Testosterone in men from A Houston PhD led Biomedical research firm. Technology estimated value up to 10 Billion Dollars.
GlobeNewswire - Wed Aug 14, 3:00PM CDT
Symmetry Technologies Inc. (OTC:SMMR) is pleased to announce the acquisition from a Houston, PhD led Biomedical research firm, all work product, rights, and interest in the "Inducible Expression System for Biosynthetic Production of Testosterone in Men" being developed by them.
Symmetry Technologies Inc. licenses a Human Rejuvenation Nutraceutical product from an FDA compliant laboratory. It will sell under the name "Resurgencell" in the yearly $200 billion USD Nutraceutical market
GlobeNewswire - Thu Aug 01, 3:04PM CDT
Symmetry Technologies Inc. (OTC:SMMR) is pleased to announce that it has licensed a Human Rejuvenation Nutraceutical product for retail sale from a US based FDA compliant laboratory that it will sell under the brand name "Resurgencell".
(0)
(0)Symmetry Technologies, Inc. (SMMR) Stock Research Links
Scroll down for more posts ▼